Characterization of new stable ghrelin analogs with prolonged orexigenic potency

. 2012 Mar ; 340 (3) : 781-6. [epub] 20111219

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid22182933
Odkazy

PubMed 22182933
DOI 10.1124/jpet.111.185371
PII: S0022-3565(24)46777-3
Knihovny.cz E-zdroje

Ghrelin, the only known peripherally produced and centrally acting peptide that stimulates food intake, is synthesized primarily in the stomach and acts through the growth hormone secretagogue receptor (GHS-R1a). In addition to its orexigenic effect, ghrelin stimulates the release of growth hormone (GH). In this study, we investigated the biological properties of full-length and shortened ghrelin analogs in which octanoylated Ser(3) is replaced with an octanoic acid moiety coupled to diaminopropionic acid (Dpr). Ghrelin analogs stabilized with Dpr(N-octanoyl) in position 3 and noncoded amino acids in position 1 (sarcosine) and/or position 4 (naphthylalanine or cyclohexylalanine) were found to possess affinities similar to those of ghrelin for cell membranes with transfected GHS-R1a. In vivo, the prolonged orexigenic effects of analogs containing Dpr(N-octanoyl)(3) compared with that of ghrelin in adult mice and a similar impact on GH secretion in young mice were found. Full-length [Dpr(N-octanoyl)(3)]ghrelin and its analogs with a noncoded amino acid in position 1 and/or 4 showed significantly prolonged stability in blood plasma compared with that of ghrelin. Ghrelin analogs with a prolonged orexigenic effect are potential treatments for GH deficiency or cachexia that accompanies chronic diseases. Desoctanoylated ghrelin analogs and N-terminal penta- and octapeptides of ghrelin did not show any biological activity.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Late-stage labeling of diverse peptides and proteins with iodine-125

. 2025 Jul ; 15 (7) : 101198. [epub] 20250117

Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease

. 2025 Feb 11 ; 20 (1) : 18. [epub] 20250211

Lipidization as a tool toward peptide therapeutics

. 2023 Dec ; 30 (1) : 2284685. [epub] 20231127

High-Fat Diet Induces Resistance to Ghrelin and LEAP2 Peptide Analogs in Mice

. 2023 Nov 28 ; 72 (5) : 607-619.

Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study

. 2021 Aug 18 ; 22 (16) : . [epub] 20210818

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides

. 2020 ; 11 () : 597583. [epub] 20201126

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity

. 2017 ; 12 (8) : e0183449. [epub] 20170818

Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration

. 2015 Jun ; 39 (6) : 986-93. [epub] 20150316

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...